Page last updated: 2024-09-05

varenicline and Diabetes Mellitus, Type 2

varenicline has been researched along with Diabetes Mellitus, Type 2 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Alamo, A; Caci, G; Campagna, D; Caponnetto, P; Cibella, F; Di Mauro, M; Franek, E; Frittitta, L; Krysinski, A; Maglia, M; Polosa, R; Russo, C; Walicka, M1
Alamo, A; Campagna, D; Caponnetto, P; Cibella, F; Di Mauro, M; Franek, E; Frittitta, L; Krysiński, A; Leotta, C; Maglia, M; Mondati, E; Polosa, R; Russo, C1
Abughosh, SM; Chen, H; Essien, EJ; Johnson, ML; Peters, RJ; Wu, IH; Yang, M1
Cedillo, S; Fernández de Bobadilla, J; Jiménez-Ruiz, CA; Rejas-Gutiérrez, J; Sicras-Mainar, A1
Anthenelli, RM1

Trials

2 trial(s) available for varenicline and Diabetes Mellitus, Type 2

ArticleYear
Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
    JAMA network open, 2022, 06-01, Volume: 5, Issue:6

    Topics: Benzazepines; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Varenicline

2022
A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol.
    Internal and emergency medicine, 2021, Volume: 16, Issue:7

    Topics: Adult; Aged; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Male; Middle Aged; Smoking Cessation; Smoking Cessation Agents; Tobacco Use Disorder; Treatment Outcome; Varenicline; Young Adult

2021

Other Studies

3 other study(ies) available for varenicline and Diabetes Mellitus, Type 2

ArticleYear
Comparison of Diabetes Risk Following Smoking Cessation Treatment Using Varenicline Versus Bupropion Among Obese Smokers.
    Substance use & misuse, 2015, Volume: 50, Issue:13

    Topics: Adolescent; Adult; Aged; Bupropion; Cohort Studies; Comorbidity; Diabetes Mellitus, Type 2; Dopamine Uptake Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Nicotinic Agonists; Obesity; Proportional Hazards Models; Retrospective Studies; Risk; Smoking; Smoking Cessation; Varenicline; Young Adult

2015
Budgetary Impact Analysis of Reimbursement Varenicline for the Smoking-Cessation Treatment in Patients with Cardiovascular Diseases, Chronic Obstructive Pulmonary Disease or Type-2 Diabetes Mellitus: A National Health System Perspective.
    European addiction research, 2017, Volume: 23, Issue:1

    Topics: Adult; Aged; Cardiovascular Diseases; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Female; Health Care Costs; Humans; Insurance, Health, Reimbursement; Male; Markov Chains; Middle Aged; Models, Economic; Pulmonary Disease, Chronic Obstructive; Smoking Cessation; Spain; Varenicline

2017
A call to action: new treatment options provide even more reasons to intervene in tobacco dependence.
    Nature clinical practice. Cardiovascular medicine, 2007, Volume: 4, Issue:9

    Topics: Benzazepines; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Obesity; Piperidines; Prevalence; Pyrazoles; Quinoxalines; Rimonabant; Risk Factors; Smoking; Smoking Cessation; Tobacco Use Disorder; Varenicline

2007